Hints and tips:
...Amgen, for instance, is trying to launch the first biosimilar of Humira, while simultaneously fighting the introduction of a copycat version of its drug, Enbrel, by Novartis, the Swiss pharma group....
...It drives growth and attracts a wealth of global corporations, investors and charities....
...He then went on to run Heinz’s European business until he joined Novartis as head of consumer health in 2007, rising to head of pharmaceutical operations....
...Mr Vasella was the driving force at Novartis after its creation from the 1996 merger of Sandoz with Ciba-Geigy....
...following its formation by the merger of Sandoz and Ciba-Geigy....
...It has also received milestone payments from Novartis and Sandoz, the Swiss company’s generics arm, for another drug targeted at both chronic obstructive pulmonary disorder and asthma. ……………………………....
...Daniel Vasella, although only 53, has become the doyen of the sector, a decade after he was named the first chief executive of Novartis, the Swiss group formed by the merger of Sandoz and Ciba-Geigy, in...
...When pharmaceuticals company Novartis was formed with the merger of Ciba-Geigy and Sandoz in 1996, the proposed management style for the new company reflected the desired transformation: “We listen more...
...Novartis now operates the world's largest generics business after paying €6bn to merge the German group Hexel with its Sandoz subsidiary....
...Geschke, Founder and Chairman, Adobe Systems, Inc. Charles K. Gifford, Chairman, Bank of America Corporation Rob Glaser, Founder, Chairman and CEO, RealNetworks, Inc. Donald J....
International Edition